Gabriele Kaltenecker
Karlsruhe, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prediction of dose reductions and impact of reduced starting doses of CDK4/6i on effectiveness in HR-positive/HER2-negative metastatic breast cancer: Real-world data from the OPAL registry.
Journal: International journal of cancer
Published: August 06, 2025
Head-to-head comparison of palbociclib and ribociclib in first-line treatment of HR-positive/HER2-negative metastatic breast cancer with real-world data from the OPAL registry.
Journal: International journal of cancer
Published: July 31, 2024
Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study.
Journal: Breast cancer research and treatment
Published: July 16, 2023
Axillary Staging after Neoadjuvant Chemotherapy for Initially Node-Positive Breast Carcinoma in Germany: Initial Data from the AXSANA study.
Journal: Geburtshilfe und Frauenheilkunde
Published: November 15, 2021
A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients.
Journal: Annals of surgery
Published: November 06, 2020
Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients.
Journal: Breast care (Basel, Switzerland)
Published: September 20, 2019
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes.
Journal: BMC cancer
Published: October 31, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026